Back to search

Article

RFC4 Drives Temozolomide Resistance in Glioblastoma by Activating STK38-BECN1-Dependent Autophagy

2025-06-24

Abstract excerpt

<title>Abstract</title> <p>Glioblastoma (GBM) remains intractable owing to treatment resistance and near-inevitable relapse. While autophagy has been demonstrated to contribute to temozolomide (TMZ) resistance, its regulatory mechanisms remain unclear. RFC4, a replication factor implicated in tumor progression, has not yet been systematically investigated in glioma for its potential role in autophagy regulation....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d3f37670-8a1f-5062-a6f4-a927cd089a87
DOI
10.21203/rs.3.rs-6854944/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
RFC4 Drives Temozolomide Resistance in Glioblastoma by Activating STK38-BECN1-Dependent AutophagyDOI 10.21203/rs.3.rs-6854944/v1
Select a neighboring publication to make it the new centre.